Pharmaron Beijing Co., Ltd. (SHE:300759)

China · Delayed Price · Currency is CNY

30.47

-0.92 (-2.93%)

Apr 17, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Macromolecule and Cell and Gene Therapy Services	474.69M	407.52M	424.94M	351.03M	150.97M
Macromolecule and Cell and Gene Therapy Services Growth	16.48%	-4.10%	21.06%	132.52%	466.58%
Laboratory Services (Excl. Macromolecule and Cell and Gene Therapy Services)	8.16B	7.05B	6.66B	-	4.57B
Laboratory Services (Excl. Macromolecule and Cell and Gene Therapy Services) Growth	15.78%	5.81%	-	-	41.09%
Chemical and formulation process development and manufacturing services	3.48B	2.99B	2.71B	2.41B	1.75B
Chemical and formulation process development and manufacturing services Growth	16.53%	10.24%	12.64%	37.83%	42.90%
Clinical Research Services	1.96B	1.83B	1.74B	1.39B	956.36M
Clinical Research Services Growth	7.14%	5.12%	24.66%	45.72%	51.96%
Others	21.90M	6.40M	4.61M	26.19M	24.48M
Others Growth	242.23%	38.79%	-82.39%	6.99%	25.21%
Laboratory Services	-	-	-	6.09B	-
Total	14.10B	12.28B	11.54B	10.27B	7.44B
Total Growth	14.82%	6.39%	12.39%	37.92%	45.00%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
North America	8.71B	7.85B	7.40B	6.64B	4.78B
North America Growth	10.97%	6.11%	11.39%	39.03%	46.08%
Europe	2.89B	2.27B	1.84B	1.48B	1.16B
Europe Growth	27.42%	23.18%	24.35%	27.52%	18.71%
Mainland China	2.14B	1.85B	1.97B	1.88B	1.27B
Mainland China Growth	15.69%	-6.46%	5.02%	47.50%	82.08%
Asia (Excluding Chinese Mainland)	298.44M	264.27M	269.04M	233.48M	192.87M
Asia (Excluding Chinese Mainland) Growth	12.93%	-1.77%	15.23%	21.05%	34.95%
Others	50.69M	39.51M	48.87M	25.01M	33.96M
Others Growth	28.32%	-19.17%	95.40%	-26.34%	-13.61%
Total	14.10B	12.28B	11.54B	10.27B	7.44B
Total Growth	14.82%	6.39%	12.39%	37.92%	45.00%

Source: S&P Global Market Intelligence.